{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:05:33Z","timestamp":1791115533955,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bbalip.2012.08.001","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T11:33:37Z","timestamp":1344339217000},"page":"109-116","source":"Crossref","is-referenced-by-count":39,"title":["Lysophosphatidic acid: A potential mediator of osteoblast\u2013osteoclast signaling in bone"],"prefix":"10.1016","volume":"1831","author":[{"given":"Stephen M.","family":"Sims","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattapon","family":"Panupinthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Pereverzev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Jeffrey","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2012.08.001_bb0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.pathmechdis.3.121806.151431","article-title":"The osteoclast: friend or foe?","volume":"3","author":"Novack","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11914-011-0078-8","article-title":"Bone development: overview of bone cells and signaling","volume":"9","author":"Teti","year":"2011","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/er.21.2.115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1258\/acb.2008.007242","article-title":"Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity","volume":"45","author":"Hosogaya","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molmed.2005.12.001","article-title":"Emerging medicinal roles for lysophospholipid signaling","volume":"12","author":"Gardell","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","article-title":"LPA receptors: subtypes and biological actions","volume":"50","author":"Choi","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/pr.110.003111","article-title":"International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature","volume":"62","author":"Chun","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0045","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.bbamem.2006.09.026","article-title":"Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism","volume":"1768","author":"Meyer zu Heringdorf","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0050","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.yexcr.2006.02.020","article-title":"Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells","volume":"312","author":"Sugimoto","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bone.2011.12.002","article-title":"The emerging role of lysophosphatidic acid (LPA) in skeletal biology","volume":"50","author":"Blackburn","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.archoralbio.2007.08.006","article-title":"Lysophosphatidic acid-stimulated interleukin-6 and \u20108 synthesis through LPA1 receptors on human osteoblasts","volume":"53","author":"Aki","year":"2008","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/mol.107.038216","article-title":"Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis?","volume":"73","author":"Zhao","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0070","first-page":"515","article-title":"Autotaxin and lysophospholipids in rheumatoid arthritis","volume":"11","author":"Bourgoin","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1098-2299(200003)49:3<187::AID-DDR9>3.0.CO;2-F","article-title":"P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development","volume":"49","author":"Dixon","year":"2000","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11302-009-9139-1","article-title":"Expression, signaling, and function of P2X7 receptors in bone","volume":"5","author":"Grol","year":"2009","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0085","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2741\/214","article-title":"P2 receptor expression, signaling and function in osteoclasts","volume":"3","author":"Reyes","year":"2011","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.gene.2012.04.076","article-title":"Mechanical regulation of signaling pathways in bone","volume":"503","author":"Thompson","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0095","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1006\/bbrc.2001.6124","article-title":"Mechanically induced ATP release from human osteoblastic cells","volume":"289","author":"Romanello","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1359\/JBMR.041009","article-title":"Fluid shear-induced ATP secretion mediates prostaglandin release in MC3T3-E1 osteoblasts","volume":"20","author":"Genetos","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1359\/jbmr.070113","article-title":"ATP release mediates fluid flow-induced proliferation of human bone marrow stromal cells","volume":"22","author":"Riddle","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S8756-3282(00)00351-3","article-title":"Expression of P2 receptors in bone and cultured bone cells","volume":"27","author":"Hoebertz","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.coph.2010.01.003","article-title":"Purinergic signalling and bone remodelling","volume":"10","author":"Orriss","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0125","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature04886","article-title":"P2X receptors as cell-surface ATP sensors in health and disease","volume":"442","author":"Khakh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0135","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1038\/sj.emboj.7601378","article-title":"Pannexin-1 mediates large pore formation and interleukin-1\u03b2 release by the ATP-gated P2X7 receptor","volume":"25","author":"Pelegrin","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0140","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1210\/me.2003-0021","article-title":"Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption","volume":"17","author":"Ke","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0145","doi-asserted-by":"crossref","first-page":"42952","DOI":"10.1074\/jbc.M506415200","article-title":"The P2X7 nucleotide receptor mediates skeletal mechanotransduction","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0150","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1074\/jbc.M605620200","article-title":"P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid","volume":"282","author":"Panupinthu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0155","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1083\/jcb.200708037","article-title":"P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis","volume":"181","author":"Panupinthu","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1388-1981(99)00093-1","article-title":"Mammalian phospholipase D structure and regulation","volume":"1439","author":"Frohman","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0165","doi-asserted-by":"crossref","first-page":"25792","DOI":"10.1074\/jbc.M110.109322","article-title":"Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival","volume":"285","author":"Lapierre","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.abb.2008.01.011","article-title":"Osteoclast receptors and signaling","volume":"473","author":"Del Fattore","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbalip.2004.03.002","article-title":"Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages","volume":"1682","author":"Duong","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0180","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1016\/j.bmcl.2004.03.076","article-title":"Initial structure\u2013activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1\/LPA3 receptor antagonist","volume":"14","author":"Heasley","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0185","doi-asserted-by":"crossref","first-page":"9653","DOI":"10.1074\/jbc.M306662200","article-title":"Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells","volume":"279","author":"Fang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0190","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","article-title":"Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer","volume":"114","author":"Boucharaba","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0195","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1073\/pnas.0600979103","article-title":"The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases","volume":"103","author":"Boucharaba","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3727\/096504009790217399","article-title":"Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms","volume":"18","author":"Boucharaba","year":"2009","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.oraloncology.2011.08.022","article-title":"Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption","volume":"48","author":"Hwang","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0210","doi-asserted-by":"crossref","first-page":"26641","DOI":"10.1074\/jbc.M110.119909","article-title":"c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation","volume":"285","author":"McMichael","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0215","doi-asserted-by":"crossref","first-page":"e9741","DOI":"10.1371\/journal.pone.0009741","article-title":"Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts","volume":"5","author":"David","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0220","doi-asserted-by":"crossref","first-page":"41147","DOI":"10.1074\/jbc.M205063200","article-title":"Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator","volume":"277","author":"Ishida","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0225","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0230","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nm994","article-title":"A new cell-permeable peptide allows successful allogeneic islet transplantation in mice","volume":"10","author":"Noguchi","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0235","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/mp.50.3.132","article-title":"Apoptosis in bone physiology and disease","volume":"50","author":"Hughes","year":"1997","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0240","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.biochem.70.1.281","article-title":"Regulation of phosphoinositide-specific phospholipase C","volume":"70","author":"Rhee","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0245","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1071550","article-title":"G protein pathways","volume":"296","author":"Neves","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0250","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0255","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bone.2007.08.044","article-title":"Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway","volume":"42","author":"Pereverzev","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0260","doi-asserted-by":"crossref","first-page":"39871","DOI":"10.1074\/jbc.M111.295048","article-title":"Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survival","volume":"286","author":"Tanabe","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0265","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/mol.63.5.1032","article-title":"Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors","volume":"63","author":"Virag","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"Pt. 7","key":"10.1016\/j.bbalip.2012.08.001_bb0270","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1242\/jcs.113.7.1177","article-title":"Rho and Rac exert antagonistic functions on spreading of macrophage-derived multinucleated cells and are not required for actin fiber formation","volume":"113","author":"Ory","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/path.1711360104","article-title":"Calcitonin alters behaviour of isolated osteoclasts","volume":"136","author":"Chambers","year":"1982","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0280","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1074\/jbc.M206421200","article-title":"RANK ligand-induced elevation of cytosolic Ca2+ accelerates nuclear translocation of nuclear factor \u03baB in osteoclasts","volume":"278","author":"Komarova","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0285","doi-asserted-by":"crossref","first-page":"15369","DOI":"10.1016\/S0021-9258(18)98625-4","article-title":"Direct effects of platelet-activating factor on isolated rat osteoclasts. Rapid elevation of intracellular free calcium and transient retraction of pseudopods","volume":"266","author":"Wood","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0290","first-page":"E74","article-title":"Platelet-activating factor stimulates resorption by rabbit osteoclasts in vitro","volume":"264","author":"Zheng","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0295","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/jbmr.5650091114","article-title":"Platelet-activating factor induces pseudopod formation in calcitonin-treated rabbit osteoclasts","volume":"9","author":"Gravel","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0300","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1172\/JCI20504","article-title":"Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy","volume":"114","author":"Hikiji","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0305","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1073\/pnas.97.24.13384","article-title":"Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior","volume":"97","author":"Contos","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0310","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1128\/MCB.22.19.6921-6929.2002","article-title":"Characterization of lpa2 (Edg4) and lpa1\/lpa2 (Edg2\/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa2","volume":"22","author":"Contos","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0315","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bone.2011.04.018","article-title":"Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass","volume":"49","author":"Gennero","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0320","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jcb.22471","article-title":"LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4","volume":"109","author":"Liu","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2012.08.001_bb0325","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1091\/mbc.E08-03-0316","article-title":"Role of LPA4\/p2y9\/GPR23 in negative regulation of cell motility","volume":"19","author":"Lee","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbalip.2012.08.001_bb0330","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jcb.21171","article-title":"Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases","volume":"101","author":"Trebec","year":"2007","journal-title":"J. Cell. Biochem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819811200159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819811200159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T02:56:59Z","timestamp":1714273019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138819811200159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S138819811200159X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2012.08.001","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}